DEL MASTRO, Lara
 Distribuzione geografica
Continente #
AS - Asia 97
EU - Europa 66
NA - Nord America 62
SA - Sud America 10
AF - Africa 7
Totale 242
Nazione #
US - Stati Uniti d'America 58
SG - Singapore 38
HK - Hong Kong 20
DE - Germania 15
CN - Cina 12
IE - Irlanda 10
RU - Federazione Russa 10
GB - Regno Unito 8
VN - Vietnam 8
BJ - Benin 7
BR - Brasile 7
IT - Italia 5
CA - Canada 4
IN - India 4
KR - Corea 4
PL - Polonia 4
SE - Svezia 4
BD - Bangladesh 3
NL - Olanda 3
FR - Francia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AT - Austria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
ES - Italia 1
FI - Finlandia 1
ID - Indonesia 1
IL - Israele 1
IR - Iran 1
MN - Mongolia 1
PE - Perù 1
PY - Paraguay 1
UA - Ucraina 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 242
Città #
Hong Kong 20
Singapore 16
Ashburn 12
Dublin 10
Cotonou 7
Beijing 6
Munich 6
Moscow 4
Seoul 4
Amsterdam 3
Chennai 3
Frankfurt am Main 3
Ho Chi Minh City 3
London 3
Los Angeles 3
Milan 3
Warsaw 3
Boardman 2
Brooklyn 2
Buffalo 2
Nuremberg 2
Roubaix 2
Stockholm 2
Asunción 1
Bandar Seri Begawan 1
Bremen 1
Calgary 1
Can Tho 1
Caxias do Sul 1
Chandler 1
City of London 1
Curitiba 1
Dallas 1
Denver 1
Dhaka 1
Guarulhos 1
Haiphong 1
Houston 1
Hyattsville 1
Jakarta 1
Lawrence 1
Lima 1
Manama 1
Manaus 1
Maracay 1
Miami 1
Montréal 1
New York 1
Orem 1
Ottawa 1
Phoenix 1
Poplar 1
Princeton 1
Pune 1
Quixabeira 1
San Francisco 1
Santa Clara 1
Secaucus 1
Suwanee 1
São Paulo 1
Tashkent 1
Teixeira de Freitas 1
Tel Aviv 1
Thái Bình 1
Tianjin 1
Tirana 1
Toronto 1
Trumbull 1
Turku 1
Ulan Bator 1
Wroclaw 1
Zanjan 1
Totale 170
Nome #
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry 74
Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patients 48
The association of financial difficulties with clinical outcomes in cancer patients: Secondary analysis of 16 academic prospective clinical trials conducted in Italy 43
Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial 42
Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system 41
Totale 248
Categoria #
all - tutte 1.521
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.521


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225 0 0 0 0 0 0 0 0 3 1 0 1
2022/202316 2 0 1 0 1 1 1 0 9 0 1 0
2023/202425 0 0 5 1 1 0 8 0 0 0 4 6
2024/202579 0 0 4 0 1 6 9 10 18 7 1 23
2025/2026123 11 10 15 35 36 16 0 0 0 0 0 0
Totale 248